In the first quarter of this year, CJ Group's health and beauty drugstore, CJ Olive Young, experienced a significant increase in sales, reaching 1.08 trillion won, marking a 30 percent rise from the same period last year. The company credited this success to strong sales in foreign markets and a rise in the number of international visitors to Korea. The company also highlighted its improved performance in exporting Korean cosmetics products and the integration of offline and online sales channels as contributing factors to its success. Furthermore, the company's overseas sales and global online mall membership also saw substantial growth. Following the recent exit of Glenwood Private Equity, which sold a 22.56 percent stake in CJ Olive Young to CJ Group, industry experts speculate that CJ Olive Young may opt to merge with CJ Group instead of pursuing its initial plan to go public. This potential merger could be a simpler alternative, as it aligns with CJ Group's efforts to strengthen the owner family's succession plan. As the biggest shareholder of CJ Olive Young, CJ Group holds a 51.15 percent stake, and there is a possibility that the eldest son of CJ Group Chairman Lee Jae-hyun could secure around 20 percent stake in CJ Group assuming Olive Young's value is estimated at 4 to 5 trillion won.